Global and China Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Intravenous
1.2.3 Intratumoral
1.2.4 Intraperitoneal
1.3 Market by Application
1.3.1 Global Gene Therapy for Ovarian Cancer Market Share by Application: 2020 VS 2026
1.3.2 Ovarian Cancer (unspecified)
1.3.3 Recurrent Ovarian Epithelial Cancer
1.3.4 Platinum-Resistant Ovarian Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy for Ovarian Cancer Market Perspective (2015-2026)
2.2 Global Gene Therapy for Ovarian Cancer Growth Trends by Regions
2.2.1 Gene Therapy for Ovarian Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy for Ovarian Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy for Ovarian Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy for Ovarian Cancer Players by Market Size
3.1.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Players (2015-2020)
3.2 Global Gene Therapy for Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy for Ovarian Cancer Revenue
3.4 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio
3.4.1 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Ovarian Cancer Revenue in 2019
3.5 Key Players Gene Therapy for Ovarian Cancer Area Served
3.6 Key Players Gene Therapy for Ovarian Cancer Product Solution and Service
3.7 Date of Enter into Gene Therapy for Ovarian Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for Ovarian Cancer Breakdown Data by Type (2015-2026)
4.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2021-2026)
5 Gene Therapy for Ovarian Cancer Breakdown Data by Application (2015-2026)
5.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Application (2015-2020)
5.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gene Therapy for Ovarian Cancer Market Size (2015-2026)
6.2 North America Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
6.3 North America Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)
6.4 North America Gene Therapy for Ovarian Cancer Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Gene Therapy for Ovarian Cancer Market Size (2015-2026)
7.2 Europe Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
7.3 Europe Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)
7.4 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Gene Therapy for Ovarian Cancer Market Size (2015-2026)
8.2 China Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
8.3 China Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)
8.4 China Gene Therapy for Ovarian Cancer Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Gene Therapy for Ovarian Cancer Market Size (2015-2026)
9.2 Japan Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
9.3 Japan Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)
9.4 Japan Gene Therapy for Ovarian Cancer Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Gene Therapy for Ovarian Cancer Market Size (2015-2026)
10.2 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020)
10.3 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020)
10.4 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Takara Bio
11.1.1 Takara Bio Company Details
11.1.2 Takara Bio Business Overview
11.1.3 Takara Bio Gene Therapy for Ovarian Cancer Introduction
11.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020))
11.1.5 Takara Bio Recent Development
11.2 VBL Therapeutics
11.2.1 VBL Therapeutics Company Details
11.2.2 VBL Therapeutics Business Overview
11.2.3 VBL Therapeutics Gene Therapy for Ovarian Cancer Introduction
11.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020)
11.2.5 VBL Therapeutics Recent Development
11.3 CELSION
11.3.1 CELSION Company Details
11.3.2 CELSION Business Overview
11.3.3 CELSION Gene Therapy for Ovarian Cancer Introduction
11.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020)
11.3.5 CELSION Recent Development
11.4 Targovax
11.4.1 Targovax Company Details
11.4.2 Targovax Business Overview
11.4.3 Targovax Gene Therapy for Ovarian Cancer Introduction
11.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020)
11.4.5 Targovax Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Intravenous
Table 4. Key Players of Intratumoral
Table 5. Key Players of Intraperitoneal
Table 6. Global Gene Therapy for Ovarian Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Gene Therapy for Ovarian Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Gene Therapy for Ovarian Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2015-2020)
Table 10. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2021-2026)
Table 12. Gene Therapy for Ovarian Cancer Market Market Trends
Table 13. Gene Therapy for Ovarian Cancer Market Drivers
Table 14. Gene Therapy for Ovarian Cancer Market Challenges
Table 15. Gene Therapy for Ovarian Cancer Market Restraints
Table 16. Global Gene Therapy for Ovarian Cancer Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Gene Therapy for Ovarian Cancer Market Share by Players (2015-2020)
Table 18. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2019)
Table 19. Global Gene Therapy for Ovarian Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Therapy for Ovarian Cancer Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Gene Therapy for Ovarian Cancer Market Size Share by Type (2015-2020)
Table 25. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2021-2026)
Table 26. Global Gene Therapy for Ovarian Cancer Market Size Share by Application (2015-2020)
Table 27. Global Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Gene Therapy for Ovarian Cancer Market Size Share by Application (2021-2026)
Table 29. North America Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 31. North America Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 33. North America Gene Therapy for Ovarian Cancer Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Gene Therapy for Ovarian Cancer Market Share by Country (2015-2020)
Table 35. Europe Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 37. Europe Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 39. Europe Gene Therapy for Ovarian Cancer Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Gene Therapy for Ovarian Cancer Market Share by Country (2015-2020)
Table 41. China Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (US$ Million)
Table 42. China Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 43. China Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (US$ Million)
Table 44. China Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 45. China Gene Therapy for Ovarian Cancer Market Size by Region (US$ Million) (2015-2020)
Table 46. China Gene Therapy for Ovarian Cancer Market Share by Region (2015-2020)
Table 47. Japan Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 49. Japan Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 51. Japan Gene Therapy for Ovarian Cancer Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Gene Therapy for Ovarian Cancer Market Share by Country (2015-2020)
Table 53. Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Gene Therapy for Ovarian Cancer Market Share by Type (2015-2020)
Table 55. Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Gene Therapy for Ovarian Cancer Market Share by Application (2015-2020)
Table 57. Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Gene Therapy for Ovarian Cancer Market Share by Country (2015-2020)
Table 59. Takara Bio Company Details
Table 60. Takara Bio Business Overview
Table 61. Takara Bio Product
Table 62. Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020) (US$ Million)
Table 63. Takara Bio Recent Development
Table 64. VBL Therapeutics Company Details
Table 65. VBL Therapeutics Business Overview
Table 66. VBL Therapeutics Product
Table 67. VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020) (US$ Million)
Table 68. VBL Therapeutics Recent Development
Table 69. CELSION Company Details
Table 70. CELSION Business Overview
Table 71. CELSION Product
Table 72. CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020) (US$ Million)
Table 73. CELSION Recent Development
Table 74. Targovax Company Details
Table 75. Targovax Business Overview
Table 76. Targovax Product
Table 77. Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2015-2020) (US$ Million)
Table 78. Targovax Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Gene Therapy for Ovarian Cancer Market Share by Type: 2020 VS 2026
Figure 2. Intravenous Features
Figure 3. Intratumoral Features
Figure 4. Intraperitoneal Features
Figure 5. Global Gene Therapy for Ovarian Cancer Market Share by Application: 2020 VS 2026
Figure 6. Ovarian Cancer (unspecified) Case Studies
Figure 7. Recurrent Ovarian Epithelial Cancer Case Studies
Figure 8. Platinum-Resistant Ovarian Cancer Case Studies
Figure 9. Gene Therapy for Ovarian Cancer Report Years Considered
Figure 10. Global Gene Therapy for Ovarian Cancer Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Gene Therapy for Ovarian Cancer Market Share by Regions: 2020 VS 2026
Figure 12. Global Gene Therapy for Ovarian Cancer Market Share by Regions (2021-2026)
Figure 13. Global Gene Therapy for Ovarian Cancer Market Share by Players in 2019
Figure 14. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy for Ovarian Cancer Revenue in 2019
Figure 16. North America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Gene Therapy for Ovarian Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Takara Bio Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2015-2020)
Figure 44. VBL Therapeutics Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2015-2020)
Figure 45. CELSION Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2015-2020)
Figure 46. Targovax Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed